U.S. senators appeared close to finalizing a bill that would require pharmacies that compound and sell sterile drugs across state lines to submit to greater federal regulation. The proposed legislation comes in the wake of a meningitis outbreak last fall …
The head of the U.S. Food and Drug Administration conceded on Tuesday that the agency could have been more aggressive in its oversight of the compounding pharmacy at the center of a deadly meningitis outbreak. Testifying at a contentious congressional …
U.S. and state health regulators called on Congress on Tuesday to strengthen federal oversight of compounding pharmacies as lawmakers prepared for two days of hearings on a deadly fungal meningitis outbreak linked to a compounded steroid. But the main federal …
